What is the primary financial impact on CBOT Holdings shareholders from this amendment?

CBOT Holdings Class A shareholders will receive a one-time cash dividend of $9.14 per share. This dividend will be declared by CBOT Holdings and paid immediately prior to the completion of the merger, assuming all conditions are satisfied.

How are the Chicago Board Options Exchange (CBOE) exercise rights (ERPs) being handled?

Eligible CBOE ERP holders have two options: they can continue as class members in the CBOE lawsuit with a guaranteed payment of up to $250,000, or they can sell their ERPs to CBOT for $250,000, payable after the merger closes. This provides a clear resolution path for these rights.

What is the significance of the veto authority granted to a committee of CME Group directors over CBOT rule changes?

The five-person committee, which includes three CBOT directors, has veto authority over CBOT rule changes, including member fees, that could materially impair the business opportunities of CBOT members. This arrangement is in place until the 2012 Annual Meeting of Stockholders and ensures that the integration process considers the interests of CBOT members and their business opportunities, fostering a smoother transition.

How does this amendment affect the timeline or conditions of the merger?

This amendment is primarily focused on resolving financial and legal aspects for stakeholders of CBOT Holdings and CBOE, particularly concerning the dividend distribution and ERPs, to facilitate the completion of the merger. It does not explicitly change the overall merger timeline but addresses key conditions and stakeholder arrangements that would precede closing.

CME 8-K: Material Agreements

Summary

CME Group Inc. (CME) filed an 8-K on June 14, 2007, detailing significant amendments to its merger agreement with CBOT Holdings, Inc. (CBOT). The primary focus for investors is the financial impact of these amendments on CBOT shareholders and the ongoing integration of the two entities. A key change is the introduction of a one-time cash dividend of $9.14 per share for CBOT Holdings Class A shareholders, to be paid immediately before the merger's completion, provided all conditions are met. Furthermore, the amendment addresses the resolution of outstanding exercise rights (ERPs) for Chicago Board Options Exchange (CBOE) members, offering them a choice between continued participation in a lawsuit with a guaranteed payment of up to $250,000, or selling their ERPs to CBOT for $250,000. This move aims to streamline the merger process by resolving potential litigation hurdles. The filing also highlights extended governance arrangements, with CBOT directors having veto power over certain CBOT rule changes until the 2012 annual meeting and continued board representation, indicating a commitment to a smooth integration and sustained representation for CBOT stakeholders.

Key Highlights

1Amendment No. 3 to the merger agreement between CME Holdings and CBOT Holdings was executed on June 14, 2007.
2CBOT Holdings Class A shareholders will receive a one-time cash dividend of $9.14 per share prior to the merger closing.
3Eligible CBOE ERP holders have new options: participate in a lawsuit with a guaranteed $250,000 payment or sell ERPs to CBOT for $250,000.
4CME Holdings removed the $15 million cap on costs associated with prosecuting the ERP litigation.
5A five-person committee, including three CBOT directors, will have veto authority over specific CBOT rule changes until the 2012 annual meeting.
6CBOT directors will continue to be designated to serve on the CME Group board of directors until the 2012 annual meeting.

CME GROUP INC. 8-K Report, Material Agreement (Jun 14, 2007)

Summary

Key Highlights

Frequently Asked Questions